tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Derek Archila, 146 are a BUY (66.36%), 70 are a HOLD (31.82%), 4 are a SELL (1.82%).
Analyst Derek Archila, currently employed at WELLS FARGO, carries an average stock price target met ratio of 52.22% that have a potential upside of 47.59% achieved within 154 days.
Derek Archila’s has documented 427 price targets and ratings displayed on 40 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on KYMR, Kymera Therapeutics at 02-Dec-2024.
Analyst best performing recommendations are on ARNA (ARENA PHARMACEUTICALS).
The best stock recommendation documented was for ARNA (ARENA PHARMACEUTICALS) at 12/10/2021. The price target of $71 was fulfilled within 3 days with a profit of $21.06 (42.17%) receiving and performance score of 140.57.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
$18
4 years 3 months 20 days ago
(01-Sep-2020)
4/4 (100%)
$3.19 (21.54%)
176
Hold
$34.5
$0.01 (0.03%)
$66
4 years 3 months 19 days ago
(31-Aug-2020)
1/8 (12.5%)
$0.28 (0.82%)
39
Hold
$34.5
$0.01 (0.03%)
$14
4 years 3 months 19 days ago
(31-Aug-2020)
7/7 (100%)
$0.28 (0.82%)
105
Hold
$35
$0.51 (1.48%)
$24
4 years 3 months 19 days ago
(31-Aug-2020)
7/17 (41.18%)
$0.78 (2.28%)
376
Buy
$50
$15.51 (44.97%)
$50
4 years 3 months 25 days ago
(25-Aug-2020)
0/5 (0%)
$37.24 (291.85%)
Which stock is Derek Archila is most bullish on?
Which stock is Derek Archila is most reserved on?
What Year was the first public recommendation made by Derek Archila?
